Have some news you want to share with the Oregon Bio community? Fill out our submission form.
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay Hagan (D-NC) for introducing the Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act. The following statement can be attributed to BIO President and CEO Jim Greenwood:
“The Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act will help unleash the promise of biotechnology to speed life-saving cures, novel medicines and scientific breakthroughs to patients living with debilitating diseases such as cancer, […]
FOR IMMEDIATE RELEASE – July 5, 2012
CONTACT: Dennis McNannay, Executive Director, Oregon Bioscience Assoc., (503) 548-4432
Dianne Danowski Smith, Oregon Bio board member, (503) 201-7019
CONTINUED GROWTH IN OREGON’S BIOSCIENCE INDUSTRY AGAIN CITED BY INTERNATIONAL BIO
Oregon continues as a high growth state, gaining in employment, wages and establishments, according to the world’s leading organization for biotechnology and life sciences, the Biotechnology Industry Organization (BIO)
(Portland, Ore.) — After three years of a downward recessionary impact on the bioscience industry across the U.S., Oregon kept an overall positive […]
Head-to-head study shows a natrually occurring non-toxic spray by Tec Labs treats human head lice effectively when compared to the common pesticide formula
(Albany, Ore.)- The surprising results of a new study1 show a safe, non-toxic solution, which is widely available over the counter, is effective at treating head lice infestations. A simple solution used by a growing number of consumers, shows the naturally occurring ingredient sodium chloride is safe for adults and children.
The preliminary study compared the results of applying sodium chloride versus permethrin, a synthetic insecticide. Many lice treatments use permethrin, which has been a standard lice treatment for decades. The […]
FEI Reports Record Revenue and EPS for the Fourth Quarter and 2011
HILLSBORO, Ore., Feb. 8, 2012 (GLOBE NEWSWIRE) — FEI Company (Nasdaq:FEIC) reported record revenue and earnings for 2011 and for the fourth quarter. Revenue and earnings per share computed on the basis of accounting principles generally accepted in the United States (“GAAP”) were the highest of any quarter in the company’s history. Several items had an impact on the fourth quarter GAAP results, as detailed below and in the […]
Bend Research Signs License Agreement With Eli Lilly and Company
Under the terms of the agreement, Bend Research will make its proprietary spray-dried dispersion (SDD) technology available to Lilly. This technology, which improves the bioavailability of compounds with low aqueous solubility, has been applied successfully to hundreds of compounds at various stages of development, from preclinical studies to Phase III clinical trials. Lilly formulators and scientists will also have broad access to Bend Research’s portfolio of other drug-delivery technologies.
In addition, as […]